Manufacturer record
Forgo Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Forgo Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between January 2024 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Forgo Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP 650mg | FT5427Mfg 2025-10 · Exp 2027-09 | The sample does not conforms to the I.P. with respect to Dissolution Test.Dissolution | DTL BikanerState lab | Jul 2026 |
| Levodropropizine & Chlorpheniramine Maleate Syrup | FL5024Mfg 2025-06 · Exp 2027-05 | The sample does not conform to Manufacturer's specification with respect to test for'pH and Assay of Chlorpheniramine Maleate.Assay | CDL, KolkataCDSCO lab | Jul 2026 |
| Capiwash Mouthwah | FL-050BMfg 2023-08 · Exp 2025-07 | Sample does not conform to IP Specification for Chlorhexidine Mouthwash IP with respect to the content of Chlorhexidine Gluconate in Chlorhexidine Gluconate Solution.Other | DTL MaduraiState lab | Dec 2024 |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP. (Folcet- MT) | FPT-2067Mfg 2022-10 · Exp 2024-09 | Assay/Content of MontelukastAssay | RDTL GuwahatiState lab | Jan 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.